Neoadjuvant Systemic Therapy Induces Fair Response Rate for High-Risk Retroperitoneal Sarcoma
Cancer Network,
Responses to neoadjuvant systemic therapy in patients with high-risk retroperitoneal sarcoma (RPS) led to clinical benefit in…
Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group
Overview of attention for article published in Cancer (0008543X), November 2020
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (94th percentile)
-
High Attention Score compared to outputs of the same age and source (85th percentile)
Readers on
- mendeley
- 34 Mendeley